Pharmacologic treatment of hyperthyroidism during lactation
- PMID: 19675263
- PMCID: PMC2726094
Pharmacologic treatment of hyperthyroidism during lactation
Abstract
Question: I have a patient who has hyperthyroidism due to Graves disease. She was taking methimazole but discontinued when she found out she was pregnant. She is currently close to delivery and might require antithyroid therapy in the postpartum period. Can methimazole cross into human milk, and is breastfeeding safe for her infant?
Answer: The exposure of infants to methimazole or propylthiouracil through breast milk is minimal and not clinically significant. Women with hyperthyroidism using methimazole or propylthiouracil should not be discouraged from breastfeeding, as the benefits of breastfeeding largely outweigh the theoretical minimal risks.
QUESTION Une de mes patientes fait de l’hyperthyroïdie à cause de la maladie de Graves. Elle prenait du méthimazole, mais a cessé quand elle a appris qu’elle était enceinte. Elle accouchera bientôt et pourrait avoir besoin d’une thérapie antithyroïdienne après la naissance. Le méthimazole est-il transmis dans le lait maternel, et l’allaitement est-il sans danger pour le nourrisson?
RÉPONSE L’exposition des nourrissons au méthimazole ou au propylthiouracil dans le lait maternel est minimale et peu significative sur le plan clinique. Il ne faut pas décourager les femmes atteintes d’hyperthyroïdie qui prennent du méthimazole ou du propylthiouracil d’allaiter puisque les bienfaits de l’allaitement dépassent largement les risques théoriques minimaux.
Similar articles
-
Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.Semin Reprod Med. 2016 Nov;34(6):317-322. doi: 10.1055/s-0036-1593489. Epub 2016 Oct 14. Semin Reprod Med. 2016. PMID: 27741549 Review.
-
Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.Pediatr Endocrinol Rev. 2010 Sep;8(1):25-33. Pediatr Endocrinol Rev. 2010. PMID: 21037541 Review.
-
Pharmacologic treatment of hyperthyroidism during pregnancy.Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):612-9. doi: 10.1002/bdra.23012. Epub 2012 Apr 18. Birth Defects Res A Clin Mol Teratol. 2012. PMID: 22511519 Review.
-
Management of hyperthyroidism during pregnancy and lactation.Eur J Endocrinol. 2011 Jun;164(6):871-6. doi: 10.1530/EJE-10-1030. Epub 2011 Mar 9. Eur J Endocrinol. 2011. PMID: 21389085 Review.
-
Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.Clinics (Sao Paulo). 2015 Jun;70(6):453-9. doi: 10.6061/clinics/2015(06)12. Epub 2015 Jun 1. Clinics (Sao Paulo). 2015. PMID: 26106966 Free PMC article. Review.
Cited by
-
A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.Turk J Med Sci. 2019 Jun 18;49(3):715-722. doi: 10.3906/sag-1808-67. Turk J Med Sci. 2019. PMID: 31023005 Free PMC article. Clinical Trial.
-
Benign thyroid disease in pregnancy: A state of the art review.J Clin Transl Endocrinol. 2016 Nov 23;6:37-49. doi: 10.1016/j.jcte.2016.11.001. eCollection 2016 Dec. J Clin Transl Endocrinol. 2016. PMID: 29067240 Free PMC article. Review.
-
Thyroid disorders in pregnancy and postpartum.Aust Prescr. 2017 Dec;40(6):214-219. doi: 10.18773/austprescr.2017.075. Epub 2017 Dec 4. Aust Prescr. 2017. PMID: 29375183 Free PMC article. Review. No abstract available.
References
-
- Humar M, Dohrmann H, Stein P, Andriopoulos N, Goebel U, Roesslein M, et al. Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha. J Pharmacol Exp Ther. 2008;324(3):1037–44. Epub 2007 Nov 30. - PubMed
-
- Davidson B, Soodak M, Neary JT, Strout HV, Kieffer JD, Mover H, et al. The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings. Endocrinology. 1978;103(3):871–82. - PubMed
-
- Van Doorn J, Roelfsema F, van der Heide D. The effect of propylthiouracil and methimazole on the peripheral conversion of thyroxine to 3,5,3’-triiodothyronine in athyreotic thyroxine-maintained rats. Acta Endocrinol (Copenh) 1983;103(4):509–20. - PubMed
-
- Beck-Peccoz P, Persani L, LaFranchi S. Safety of medications and hormones used in the treatment of pediatric thyroid disorders. Pediatr Endocrinol Rev. 2004;2(Suppl 1):124–33. - PubMed
-
- Streetman DD, Khanderia U. Diagnosis and treatment of Graves disease. Ann Pharmacother. 2003;37(7–8):1100–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical